期刊
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
卷 49, 期 4, 页码 445-452出版社
WILEY
DOI: 10.1111/1440-1681.13622
关键词
breast cancer; cancer therapy; malignancy; microtubule; stathmin; tau
Breast cancer is a common malignant tumor in women, and chemotherapy may lead to multidrug resistance. Recent studies have shown that the upregulation of stathmin and tau expression in various malignant tumors may promote the occurrence and progression of cancer. This literature review summarizes the expression of these two proteins in breast cancer and their involvement in treatment methods.
Breast cancer is the most common malignant neoplasm among women, responsible for 30% of all malignant tumours, and the second most significant reason of cancer fatality in women. Treatment failure and tumour recurrence are common outcomes of chemotherapy when patients develop multidrug resistance (MDR). New therapeutic methods like molecularly targeted therapeutic interventions need a thorough understanding of malignant tumour's molecular processes. Numerous studies published in the last few years indicate that stathmin and tubulin-associated units (tau) are upregulated in a range of human malignant tumours, suggesting that they may enhance the incidence and progression of malignancies. By promoting cancer cell reproduction, infiltration and generating drug resistance, these proteins aid in the disease's development. Existing information on the expression of tau protein and stathmin in breast cancer, as well as their involvement in treatment methods, is summarized in this literature review.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据